Carlyle Group Inc. 13F Portfolio

CIK 1527166 Filing since Q1 2014 Q2 2026 filed Aug 7, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 7, 2026.

Portfolio Snapshot

19 positions · Q2 2026

Carlyle Group Inc. reported 19 positions worth $10.00B for the quarter ended Jun 30, 2026, down 5.8% on the prior quarter. It opened 3 new positions, added to 2, trimmed 2 and exited 3. Its largest holding is Medline Inc. at 73.8% of the portfolio.

Portfolio Value
$10.00B
-5.8% QoQ · +102.0% YoY
Positions
19
3 new · 3 sold out
Top 10 Concentration
99.9%
of portfolio value
Largest Position
MDLN 73.8%
Medline Inc.
Net Buying
-$19.60M
$2.78M bought · $22.38M sold
Turnover
0%
of the portfolio traded
Top Sector
Healthcare
74.2% of value
Track Record
50
quarters on file since Q1 2014

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

8 sectors
74.22%
Healthcare
Healthcare74.22%
Industrials25.33%
Real Estate0.2%
Technology0.173%
Other0.054%
Consumer Discretionary0.012%
Energy<0.01%
Financial Services<0.01%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

HealthcareIndustrialsReal EstateTechnologyOtherConsumer DiscretionaryEnergyFinancial ServicesBasic MaterialsUtilities

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
SPWR SunPower Inc. +1.91M +441.1% $1.31M 0.016%
REPX Riley Exploration Permian, Inc. +16.1K – $530.39K <0.01%
NBIS Nebius Group N.V. +1,846 – $509.81K <0.01%
METC Ramaco Resources, Inc. +21.7K – $287.67K <0.01%
HOOD Robinhood Markets, Inc. +1,357 +40.2% $136.08K <0.01%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
QTTB Q32 Bio Inc. -1.04M -94.5% $13.28M <0.01%
CUBE CubeSmart -220.5K -100.0% $8.08M Exited
HTFL Heartflow, Inc. -20.4K -100.0% $497.26K Exited
SYRE Spyre Therapeutics, Inc. -9,620 -100.0% $485.23K Exited
INVH Invitation Homes Inc. -1,200 -0.2% $36.25K 0.2%

New Positions

Q2 2026
Holding Shares Trade Value Weight
REPX Riley Exploration Permian, Inc. +16.1K $530.39K <0.01%
NBIS Nebius Group N.V. +1,846 $509.81K <0.01%
METC Ramaco Resources, Inc. +21.7K $287.67K <0.01%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
CUBE CubeSmart -220.5K $8.08M 0.076%
HTFL Heartflow, Inc. -20.4K $497.26K <0.01%
SYRE Spyre Therapeutics, Inc. -9,620 $485.23K <0.01%
Holdings · Q2 2026

19 Positions

As ofJun 30, 2026
Value$10.00B
Top 1099.9%
Avg position$526.36M
# Activity
4 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 19 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Carlyle.

About Carlyle Group Inc.’s 13F Portfolio

What are Carlyle Group Inc.’s largest holdings?

As of its Q2 2026 13F filing, Carlyle Group Inc.’s five largest positions were Medline Inc. (MDLN) at 73.8%, StandardAero, Inc. (SARO) at 25.3%, Phathom Pharmaceuticals, Inc. (PHAT) at 0.4%, Invitation Homes Inc. (INVH) at 0.2%, Pony AI Inc. (PONY) at 0.2% of the reported portfolio.

How much is Carlyle Group Inc.’s portfolio worth?

Carlyle Group Inc. reported a 13F portfolio worth $10.00B across 19 positions for Q2 2026. That is down 5.8% from the previous quarter.

What did Carlyle Group Inc. buy in Q2 2026?

Its largest purchases by value were SunPower Inc. ($1.31M), Riley Exploration Permian, Inc. ($530.39K), Nebius Group N.V. ($509.81K). It opened 3 new positions.

What did Carlyle Group Inc. sell in Q2 2026?

Its largest sales by value were Q32 Bio Inc. ($13.28M), CubeSmart ($8.08M), Heartflow, Inc. ($497.26K). It exited 3 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Carlyle Group Inc. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.